Search Results

Filter
  • 1-9 of  9 results for ""Receptor, IGF Type 1""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Report

A Perspective on the Current Role of Teprotumumab in Treatment of Thyroid Eye Disease.

Subjects: Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*therapeutic use ; Autoimmune Diseases/Autoimmune Diseases/Autoimmune Diseases/*drug therapy ; Graves Ophthalmopathy/Graves Ophthalmopathy/Graves Ophthalmopathy/*drug therapy

  • Source: Ophthalmology [Ophthalmology] 2021 Aug; Vol. 128 (8), pp. 1125-1128. Date of Electronic Publication: 2021 Apr 03.Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Response of the insulin-like growth factor (IGF) system to IGF-IR inhibition and androgen deprivation in a neoadjuvant prostate cancer trial: effects of obesity and androgen deprivation.

  • Authors : Dean JP; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.; Sprenger CC

Subjects: Neoadjuvant Therapy*; Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*drug therapy ; Androgen Antagonists/Androgen Antagonists/Androgen Antagonists/*therapeutic use

  • Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2013 May; Vol. 98 (5), pp. E820-8. Date of Electronic Publication: 2013 Mar 26.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print-Electronic

Record details

×
Academic Journal

Postmarketing Safety Concerns of Teprotumumab: A Real-World Pharmacovigilance Assessment.

  • Authors : Huang J; Division of Thyroid Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.; Su A

Subjects: Pharmacovigilance* ; Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/statistics & numerical data ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects

  • Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Dec 18; Vol. 110 (1), pp. 159-165.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited

Record details

×
Academic Journal

Early IGF-1 receptor inhibition in mice mimics preterm human brain disorders and reveals a therapeutic target.

  • Authors : Potenzieri A; Brain Development and Disease Laboratory, Istituto Italiano di Tecnologia, via Morego, 30, 16163 Genoa, Italy.; Università degli Studi di Genova, via Balbi, 5, 16126 Genoa, Italy.

Subjects: Insulin-Like Growth Factor I* ; Brain Diseases*/Brain Diseases*/Brain Diseases*/drug therapy; United States

  • Source: Science advances [Sci Adv] 2024 Mar; Vol. 10 (9), pp. eadk8123. Date of Electronic Publication: 2024 Mar 01.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication

Record details

×
Academic Journal

Teprotumumab (Tepezza): from the discovery and development of medicines to USFDA approval for active thyroid eye disease (TED) treatment.

  • Authors : Ali F; Laboratory Services, Botswana Medicines Regulatory Authority (BoMRA), Plot 112, International Finance Park, Gaborone, Botswana. .; Chorsiya A

Subjects: Graves Ophthalmopathy*/Graves Ophthalmopathy*/Graves Ophthalmopathy*/drug therapy; Antibodies, Monoclonal, Humanized ; Humans

  • Source: International ophthalmology [Int Ophthalmol] 2021 Apr; Vol. 41 (4), pp. 1549-1561. Date of Electronic Publication: 2021 Jan 22.Publisher: Kluwer Country of Publication: Netherlands NLM ID: 7904294 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2630

Record details

×
Academic Journal

Insulin resistance contributes to racial disparities in breast cancer prognosis in US women.

  • Authors : Gallagher EJ; Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, 1428 Madison Avenue, Box 1055, New York, NY, 10029, USA. .; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. .

Subjects: Insulin Resistance*; Black or African American/Black or African American/Black or African American/*statistics & numerical data ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*epidemiology

  • Source: Breast cancer research : BCR [Breast Cancer Res] 2020 May 12; Vol. 22 (1), pp. 40. Date of Electronic Publication: 2020 May 12.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Identification and functional analysis of a novel G310D variant in the insulin-like growth factor 1 receptor (IGF1R) gene associated with type 2 diabetes in American Indians.

  • Authors : Muller YL; Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, Phoenix, AZ, USA.; Skelton G

Subjects: Genetic Predisposition to Disease* ; Polymorphism, Single Nucleotide*; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*genetics

  • Source: Diabetes/metabolism research and reviews [Diabetes Metab Res Rev] 2018 May; Vol. 34 (4), pp. e2994. Date of Electronic Publication: 2018 Mar 25.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883450 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Virtual screening of specific insulin-like growth factor 1 receptor (IGF1R) inhibitors from the National Cancer Institute (NCI) molecular database.

  • Authors : Fan C; National Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University, Changchun 130024, China. .; Huang YX

Subjects: Databases, Chemical* ; Molecular Docking Simulation*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*chemistry

  • Source: International journal of molecular sciences [Int J Mol Sci] 2012 Dec 14; Vol. 13 (12), pp. 17185-209. Date of Electronic Publication: 2012 Dec 14.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

IGF gene polymorphisms and breast cancer in African-American and Hispanic women.

  • Authors : Sarkissyan M; Division of Cancer Research and Training, Center to Eliminate Cancer Health Disparities, Department of Internal Medicine, Charles Drew University of Medicine and Science, Los Angeles, CA 90059, USA.; Mishra DK

Subjects: Polymorphism, Genetic*; Black or African American/Black or African American/Black or African American/*genetics ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*genetics

  • Source: International journal of oncology [Int J Oncol] 2011 Jun; Vol. 38 (6), pp. 1663-73. Date of Electronic Publication: 2011 Mar 30.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-9 of  9 results for ""Receptor, IGF Type 1""